A revolutionary medical breakthrough gives hope to blind patients.


Thanks to retina microchip implantation, legally blind individuals can now see shapes, words, and even faces again.


This innovation turns science fiction into reality for people suffering from vision loss.


🧠 What is the Prima System?


A tiny photovoltaic microchip, the size of a grain of rice, is implanted under the retina.


Developed by scientists at Moorfields Eye Hospital in london and other european medical centers.


Part of an international clinical trial involving 38 patients across 5 countries.


🕶️ How It Works


Special glasses with cameras capture images of the surroundings.


These images are converted into infrared signals and sent to the implanted chip.


The chip turns these into electrical signals, which are passed to the brain via the optic nerve.


The brain interprets these signals as visual information, allowing patients to see again.



👁️ Real-Life Impact: Sheila’s Story


Sheila Irwin, 70, lost her central vision 30 years ago.


After receiving the implant, she could read letters on an eye chart for the first time in decades.


She said, “I feel like my whole life has changed.”


⚠️ Not a Universal Cure


This implant is effective primarily for advanced dry age-related macular degeneration (AMD).


It doesn’t cure all types of blindness.


According to the New england Journal of Medicine:


84% of patients regained reading ability.


Vision improved by up to five lines on an eye chart.


🌍 A Step Toward Hope


Dr. mahi Muqeet, lead surgeon, calls it the first functional vision implant for daily life.


Currently in clinical trials, with hopes for wider access through systems like the NHS.


A potential game-changer for millions of AMD patients worldwide.


Disclaimer:

The information contained in this article is for general informational purposes only. While we strive to ensure accuracy, we make no warranties or representations of any kind, express or implied, about the completeness, accuracy, reliability, suitability, or availability of the content. Any reliance you place on the information is strictly at your own risk. The views, opinions, or claims expressed in this article are those of the author and do not necessarily reflect the official policy or position of any organization mentioned. We disclaim any liability for any loss or damage arising directly or indirectly from the use of this article.

Find out more: